MARIA SPINOSO: Open Payments
NPI 1710492723 · BALDWIN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 46 payments from 14 companies in 2025. Trend: 2023 $588 · 2024 $634 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $192 |
| Amgen Inc. | 11 | $166 |
| ABBVIE INC. | 5 | $103 |
| Indivior Inc. | 3 | $78 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Lilly USA, LLC | 2 | $39 |
| Gilead Sciences, Inc. | 2 | $33 |
| Inspire Medical Systems, Inc. | 2 | $33 |
| Eisai Inc. | 1 | $28 |
| Esperion Therapeutics, Inc. | 1 | $22 |
Products named: OTEZLA, Ozempic, SUBLOCADE, QULIPTA, REPATHA, Saxenda, MOUNJARO, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
